Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Initial Development and Dissemination of OC-Go (OC-GoPhaseI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03126305
Recruitment Status : Enrolling by invitation
First Posted : April 24, 2017
Last Update Posted : June 18, 2018
Sponsor:
Collaborator:
Virtually Better, Inc.
Information provided by (Responsible Party):
John Piacentini, University of California, Los Angeles

Brief Summary:
The clinical component of Phase I application development examines the clinical utility, feasibility, and functionality of the OC-Go application via an 8-month pilot trial consisting of 50 standard CBT sessions augmented with OC-Go in OCD-diagnosed children who are receiving treatment through the pediatric OCD treatment programs in the UCLA Division of Child and Adolescent Psychiatry

Condition or disease Intervention/treatment
Obsessive-Compulsive Disorder Other: OC-Go

Detailed Description:
This project seeks to refine and assess OC-Go, a HIPAA-compliant web-based clinician portal and patient-side mobile application designed to increase patient adherence to evidence-based treatment (EBT) for Obsessive Compulsive Disorder (OCD), a common and impairing condition, and provider ability to effectively implement EBTs. OC-Go allows clinicians to create and push tailored assignments to patients on their mobile devices with an optimized user interface that includes patient accountability and support features. Accordingly, patients can be guided to do assignments by themselves between sessions with increased fidelity over the course of treatment. Once therapy assignments are created and shared to a crowd-sourced and curated public library, any clinician can assign any task to any patient for homework or in-session use with one touch. Use of OC-Go is expected to increase patient engagement, compliance, treatment efficiency, dissemination of EBTs, and therapist confidence and expertise.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 15 participants
Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: Facilitating Fidelity and Dissemination of Evidence Based Treatment for Childhood OCD Via an Interactive Crowd-sourced Patient-provider Tool
Estimated Study Start Date : July 1, 2018
Estimated Primary Completion Date : February 1, 2020
Estimated Study Completion Date : March 31, 2020

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
OC-Go
Approximately 10-20 9-17 year-olds receiving exposure based cognitive behavior therapy for OCD through the UCLA Division of Child and Adolescent Psychiatry OCD treatment programs
Other: OC-Go
OC-Go, a HIPAA-compliant web-based clinician portal and patient-side mobile application that allows clinicians to create and push tailored treatment assignments to patients on their mobile devices




Primary Outcome Measures :
  1. System Usability Scale (SUS) [ Time Frame: 6 weeks ]
    10-item self-report measure assessing the usability of the OC-Go application

  2. Usability Evaluation for e-Learning Applications (UELA), [ Time Frame: 6 weeks ]
    54-item self-report measure assessing the usability of the OC-Go application



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   9 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Children receiving exposure based CBT through the UCLA Child OCD, Anxiety and Tic Disorders Clinic or Pediatric OCD Intensive Outpatient Program and their parents
Criteria

Inclusion Criteria:

  • Children receiving exposure based CBT through the UCLA Child OCD, Anxiety and Tic Disorders Clinic or Pediatric OCD Intensive Outpatient Program and their parents

Exclusion Criteria:

  • None

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03126305


Locations
Layout table for location information
United States, California
Univ. of California / Los Angeles / Semel Inst.
Los Angeles, California, United States, 90024-1759
Sponsors and Collaborators
University of California, Los Angeles
Virtually Better, Inc.
Investigators
Layout table for investigator information
Principal Investigator: John Piacentini, Ph.D. University of California, Los Angeles
Principal Investigator: Peter Tuerk, Ph.D. Virtually Better, Inc.

Layout table for additonal information
Responsible Party: John Piacentini, Professor of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles
ClinicalTrials.gov Identifier: NCT03126305     History of Changes
Other Study ID Numbers: R42MH111277-01A1 ( U.S. NIH Grant/Contract )
First Posted: April 24, 2017    Key Record Dates
Last Update Posted: June 18, 2018
Last Verified: June 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by John Piacentini, University of California, Los Angeles:
exposure
response prevention
web-based application
Additional relevant MeSH terms:
Layout table for MeSH terms
Compulsive Personality Disorder
Obsessive-Compulsive Disorder
Personality Disorders
Mental Disorders
Anxiety Disorders